Trial intelligence / Profile preview

Sevelamer vs Calcium Acetate on Fetuin-A and Endothelial Dysfunction in CKD

NCT00486772Phase 4Completed

Sponsor
Gulhane School of Medicine
Modality
Polymer-based Nanoparticles, Small Molecules
01

Overview

A Phase 4 trial of sevelamer carbonate in chronic kidney disease (CKD), hyperphosphatemia, sponsored by Gulhane School of Medicine. Status: completed.

02

Drugs

sevelamer carbonate
03

Conditions

chronic kidney disease (CKD)hyperphosphatemia

Beyond the preview

Go deeper on NCT00486772.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00486772.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call